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Abstract—Electrophysiological recordings were used to in-
vestigate the effects of ATP analogues on -burst-induced
long-term potentiation (LTP) in rat hippocampal slices. ,-
Methylene ATP (,-MeATP; 20 M) decreased LTP from
369% to 175%, an effect prevented by adenosine A1 re-
ceptor blockade in accordance with the localised catabolism
of ATP analogues into adenosine, leading to adenosine A1
receptor activation. Thus, to probe the role of extracellular
ATP, all experiments were performed with the A1 receptor
selective antagonist, 1,3-dipropyl-8-cyclopentylxanthine
(50 nM). In these conditions, ,-MeATP or 5-adenylylimido-
diphosphate (,-ImATP; 20 M) facilitated LTP by 120%, an
effect prevented by the P2 receptor antagonists, pyridoxal-
phosphate-6-azophenyl-2-4-disulphonic acid (PPADS; 20 M)
or suramin (75 M), as well as by the P2X1/3-selective antago-
nist 8-(benzamido)naphthalene-1,3,5-trisulfonate (10 M). The
facilitations of LTP by either ,-MeATP or ,-ImATP (20 M)
were also prevented by both 4-(2-[7-amino-2-(2-furyl(1,2,4)-
triazolo(2,3a)-(1,3,5)triazin-5-yl-amino]ethyl)phenol (50 nM) or
7–2(-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-
triazolo[1,5-c] pyrimidine (50 nM), antagonists of facilitatory
adenosine A2A receptors, were occluded by the A2A receptor
agonist, CGS 21680 (10 nM) and were prevented by the protein
kinase C inhibitor, chelerythrine (6 M) and unaffected by the
protein kinase A inhibitor, H89 (1 M). Furthermore, ,-ImATP
(20 M) enhanced [3H]adenosine outflow from rat hippocam-
pal slices by nearly 150%, an effect prevented by PPADS
(20 M) or suramin (75 M). The adenosine transport inhibi-
tors, nitrobenzylthioinosine (5 M) and dipyridamole (10 M)
also prevented ,-ImATP (20 M)-induced [3H]adenosine
outflow and facilitation of LTP. These results suggest that
ATP analogues facilitate LTP through P2 receptor activation
that mainly triggers adenosine release leading to the activa-
tion of adenosine A2A receptors. © 2003 IBRO. Published by
Elsevier Ltd. All rights reserved.
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Both types of ATP receptors, ionotropic (P2X) and metabo-
tropic (P2Y), are widely distributed in the brain (Ralevic
and Burnstock, 1998). The P2X receptors comprise a fam-
ily of ATP-gated nonselective cation channel-receptors
that mediate fast excitatory transmission in some periph-
eral nervous system and CNS pathways (Ralevic and
Burnstock, 1998) and also have a neuromodulatory role,
particularly at the presynaptic level (reviewed in Cunha
and Ribeiro, 2000a). Seven subtypes of P2X receptors
have been cloned (P2X1–7) (North and Surprenant, 2000),
of which P2X1, P2X2, P2X4 and P2X6 have overlapping
expressions in the brain (Valera et al., 1994; Collo et al.,
1996; Se´gue´la et al., 1996; Soto et al., 1996; Tanaka et al.,
1996; Leˆ et al., 1998a). In fact, localisation of ATP recep-
tors by radioligand binding techniques (Bo and Burnstock,
1994; Balcar et al., 1995), in situ hybridisation (Valera et
al., 1994; Kidd et al., 1995; Collo et al., 1996; Soto et al.,
1996; Tanaka et al., 1996; Leˆ et al., 1998a) and immuno-
cytochemistry (Leˆ et al., 1998b; Kanjhan et al., 1999;
Worthington et al., 1999; Rubio and Soto, 2001) show a
broad distribution of P2X receptors in the brain, with the
hippocampus being one of the areas expressing the high-
est levels.
However, in the hippocampus and in other brain struc-
tures where P2X receptors are abundantly expressed, the
neuroactive role of ATP is still ill-defined. In fact, ATPergic
transmission has been demonstrated in the medial habe-
nula (Edwards et al., 1992), in the spinal cord (Bardoni et
al., 1997), in the locus coeruleus (Nieber et al., 1997) and
in the nucleus tractus solitarius (Thomas and Spyer, 2000)
whereas in the hippocampus it only contributes to less than
10% of excitatory transmission in glutamatergic synapses
(Pankratov et al., 1998; Mori et al., 2001). When probing
the effect of extracellular ATP, it is mostly concluded that
its main role is to act as a substrate for ecto-nucleotidases
yielding adenosine (Dunwiddie et al., 1997; Cunha et al.,
1998), a neuromodulator on its own (reviewed by Cunha,
2001). In fact, the inhibitory effect of ATP on basal hip-
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pocampal synaptic transmission is abolished in adenosine
A1 receptor knockout animals (Masino et al., 2002).
But, interestingly, ATP is released in greater amounts
upon conditions of high frequency stimulation (Wieraszko
et al., 1989; Cunha et al., 1996a) associated with phenom-
ena of synaptic plasticity. Use-dependent long-term
changes in synaptic efficiency, like long-term potentiation
(LTP), are thought to form the basis for learning and mem-
ory (Bliss and Collingridge, 1993). In hippocampal CA1
neurons, extracellularly applied ATP causes synaptic po-
tentiation similar to LTP (ATP-induced LTP; Wieraszko
and Seyfried, 1989; Wieraszko and Ehrlich, 1994; Fujii et
al., 1995; O’Kane and Stone, 2000). This may occur either
because extracellular ATP can play a role in ATP-induced
LTP as a orthophosphate donor for the extracellular phos-
phorylation of membrane proteins (Fujii et al., 1995; Chen
et al., 1996) or because ATP may directly control neuronal
function by activating hippocampal P2 receptors (Inoue et
al., 1996; Pankratov et al., 1998, 2002; Mori et al., 2001).
We re-evaluated the modulatory role of extracellular
ATP on synaptic plasticity in hippocampal slices now 1)
controlling for the possibility that some effects may be due
to the formation of adenosine, 2) using ATP analogues not
prone to act as phosphate donors, and 3) choosing a
-burst pattern to induce LTP, since modulatory effects
may not be observed with robust high-frequency stimula-
tion protocols (de Mendonc¸a and Ribeiro, 2001).
EXPERIMENTAL PROCEDURES
Drugs
Adenosine deaminase (type VI; 1803 U/ml; EC 3.5.4.4), S-(p-
nitrobenzyl)-6-thioinosine (NBTI), ,-methylene ATP (,-
MeATP) and 5-adenylylimido-diphosphate (,-Imido ATP) were
from Sigma (Reagente 5, Porto, Portugal), 1,3-dipropyl-8-cyclo-
pentylxanthine (DPCPX), 8-{4-[(2-aminoethyl)amino]carbonylm-
ethyl-oxyphenyl}xanthine (XAC), suramin, 2-[4-(2-p-carboxyethyl)-
phenylamino]-5-N-ethylcarboxamidoadenosine (CGS 21680),
pyridoxal phosphate-6-azophenyl-2,4-disulphonic acid (PPADS),
and 8-(benzamido)naphthalene-1,3,5-trisulfonate (NF023) were
from RBI (Reagente 5, Porto, Portugal), dipyridamole was from
Boehringer Ingelheim, 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-
a][1,3,5]triazin-5ylamino]ethyl)phenol (ZM 241385) was from Toc-
ris, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-
triazolo[1,5-c]pyrimidine (SCH 58261) was a kind gift of E. Ongini
(Shering-Plough, Milan), [2,3,8-3H]adenosine (specific activity:
55.8 Ci/mmol) and [3H]CGS 21680 (specific activity 38.4 Ci/mmol)
were from DuPont NEN (Anagene, Lisbon, Portugal) and chel-
erythrine and H89 were from Calbiochem (Darmstadt, Germany).
ZM241385, CGS 21680, XAC, dipyridamole, NBTI, H89 and
chelerythrine were made up as 5 mM stock solutions in dimethyl-
sulphoxide (DMSO). SCH 58261 was made up as a 10 mM stock
solution in DMSO. DPCPX was made up into a 5 mM stock
solution in 99% DMSO and 1% NaOH (1M). All drug stock solu-
tions were diluted directly into the superfusion solution to the
appropriate final concentration. DMSO, in the maximal concentra-
tion applied to the preparations, was devoid of effects on synaptic
plasticity experiments and [3H]adenosine release from rat hip-
pocampal slices.
Preparation of hippocampal slices
The experiments were performed on hippocampal slices taken
from male young adult Wistar rats (5–6 weeks old, from Harlan
Iberica, Barcelona, Spain) that were handled and killed according
to EU guidelines, the number of animals used being kept to an
absolute minimum for the results to reach statistical significance.
To minimise suffering, the animals were anaesthetized with halo-
thane before being decapitated, and the right hippocampus was
dissected free within an ice-cold artificial cerebrospinal fluid
(aCSF) of the following composition (in mM): NaCl 124, KCl 3,
NaH2PO4 1.25, NaHCO3 26, MgSO4 1, CaCl2 2, glucose 10, and
gassed with a 95% O2 and 5% CO2 mixture. Slices were cut
400 m thick perpendicularly to the long axis of the hippocampus
with a McIlwain tissue chopper, and kept in a resting chamber
within the same gassed aCSF at room temperature (22 °C–25 °C)
for at least 1 h to allow their energetic and functional recovery.
Electrophysiology studies
A slice was transferred to the submerged recording chamber (1 ml
capacity) where it was continuously superfused at a rate of 3 ml/
min with the same gassed solution at 30.5 °C. Stimulation (rect-
angular pulses of 0.1 ms) was delivered through a bipolar con-
centric wire electrode placed on the Schaffer collateral/commis-
sural fibers in the stratum radiatum. Two separate sets of the
Schaffer pathway (S1 and S2) were stimulated, as previously
described (Costenla et al., 1999). Responses were evoked alter-
nately on the two pathways, each pathway being stimulated once
every 20 s (basal frequency). The initial intensity of the stimulus
was that eliciting a field excitatory post-synaptic potential (fEPSP)
of about 1 mV amplitude, whilst minimising contamination by the
population spike, and of similar magnitude in both pathways.
Evoked fEPSP were recorded extracellularly from CA1 stratum
radiatum using micropipettes filled with 4 M NaCl and 2–6 M
resistance, and displayed on a Tektronix digitising oscilloscope.
The averages of eight consecutive responses from each pathway
were obtained, plotted graphically and recorded for further anal-
ysis with a personal computer using locally developed software.
The fEPSP were quantified as the slope of the initial phase of the
potential. The independence of the two pathways was tested by
using paired-pulse facilitation across both pathways, less than
10% facilitation being usually observed.
LTP was induced by a -burst stimulation pattern (three trains
of 100 Hz, each with four stimuli, separated by 200 ms). In all the
experiments, the stimulation protocol to induce LTP was applied
after having a stable baseline for at least 30 min. LTP was quan-
tified as the percentage change in the average slope of the
potentials taken from 50 to 60 min after the induction protocol, in
relation to the average slope of the fEPSP measured during the 10
min that preceded the induction protocol. LTP was always induced
in one pathway in the control conditions, and afterward induced in
the other pathway, in the presence of the drug to be tested. It is
important to note that the use of two stimulation pathways to
compare the effects of drugs on -burst-induced LTP is particu-
larly important since there is a large variation in the amplitude of
LTP between slices, whereas we confirmed that LTP amplitudes
obtained on stimulation of two independent sets of Schaffer path-
ways are similar.
[3H]adenosine release studies
The release of [3H]adenosine from rat hippocampal slices was
performed as previously described (Cunha et al., 1996a). Briefly,
the slices were resuspended in 2 ml of oxygenated aCSF, equil-
ibrated at 37 °C for 10 min and loaded with [2,3,8-3H]adenosine
(30 Ci/ml, 0.125 M) for 20 min. The excess of radioactivity was
removed by washing the preparations twice with 2 ml of oxygen-
ated aCSF at 37 °C. Groups of three slices were then placed in
100 l chambers and superfused with oxygenated aCSF at 37 °C
with a flow rate of 0.6 ml/min. After 30 min superfusion, the effluent
was collected every 2 min to quantify released tritium. When the
effect of any drug was tested, this drug was added 6 min after the
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sample collection was started, only into two chambers out of four
chambers, and remained in the bath until the end of the release
period. At the end of the experiments (22 min after starting the
sample collection), the slices were sonicated in 0.5 ml of 3 M
perchloric acid with 2% Triton X-100, and a 100 l aliquot of the
homogenised slices was used to determine the amount of tritium
retained by the preparations (Cunha et al., 1996a).
The release of [3H]adenosine from rat hippocampal synapto-
somes followed a protocol similar to that used for slices, as
previously described (Cunha et al., 2000), using 0.4–0.6 mg of
protein in each assay.
The release of [3H]adenosine from primary cultures of rat
hippocampal neurons or astrocytes was also evaluated. Hip-
pocampal neurons were dissociated from hippocampi of E18–E19
rat embryos, as previously described (Ambro´sio et al., 1999) and
cultured in serum free Neurobasal medium (GIBCO, Life Technol-
ogies, UK) with B27 supplement (GIBCO), 25 M glutamine,
0.5 mM glutamate and 0.12 mg/ml gentamicin. Cultures were
plated on poly-D-lysine-coated (0.1 mg/ml) glass coverslips at a
density of 0.2	106 cells/cm2 and kept at 37 °C in a humidified
incubator in 5% CO2/95% air for 7–8 days, the time required for
maturation of hippocampal neurons. Cultured astrocytes were
obtained from P5 rat pups and cultured in a humidified incubator
in 5% CO2/95% air for 10–14 days at 37 °C on poly-D-lysine-
coated (0.1 mg/ml) 75 cm2 Costar containers at a density of
1.14	105 cells/cm2 in Dulbecco’s Modified Eagle medium
(GIBCO) supplemented with 100 g/ml streptomycin, 100 U/ml
penicillin and 10% foetal calf serum (Seromed; e.g. Saneto and de
Vellis, 1987). These cultures of neurons or astrocytes were incu-
bated for 4 h at room temperature with aCSF solution buffered
with 25 mM HEPES (aCSF-HEPES solution) and then incubated
for a further 30 min period with [2,3,8-3H]adenosine (30 Ci/ml,
0.125 M). They were then superfused for 90 min at a flow rate of
0.5 ml/min with aCSF-HEPES solution to remove non-incorpo-
rated radioactivity, the excess of medium being removed by vac-
uum suction to ensure a constant volume of 2 ml (neurons) or 5 ml
(astrocytes). Drugs were added through this superfusion solution
and tritium release was quantified in the collected vacuum aspi-
rate after exposure of the cultures for 15 min to the tested drugs.
At the end of the experiment, the cultured neurons or astrocytes
were incubated with 0.5 or 2 ml of 3 M perchloric acid with 2%
Triton X-100, and a 100 l aliquot of the supernatant was used to
determine the amount of tritium retained by the preparations.
Radioactivity was expressed in terms of disintegrations per
second per milligram of protein (Bq/mg) in each chamber, protein
being quantified by the method of Peterson (1977). In some
experiments, a 500 l aliquot of the collected sample was sepa-
rated by HPLC and the peak corresponding to adenosine was
collected to quantify [3H]adenosine outflow, as previously de-
scribed (Cunha et al., 1996a).
Binding to adenosine A2A receptors
The competition by ATP analogues (1–1000 M) of [3H]CGS
21680 binding was performed as previously described (Cunha et
al., 1996b) using membranes from the rat hippocampus. Briefly,
[3H]CGS 21680 (30 nM) binding was carried out for 4 h at room
temperature (23–25 °C), with 242–310 g of membrane protein in
a final volume of 300 l in an incubation solution containing 50 mM
Tris–HCl and 10 mM MgCl2, pH 7.4, with 5 U/ml adenosine
deaminase. Specific binding was determined by subtraction of the
non-specific binding which was measured in the presence of 2 M
XAC. The binding reactions were stopped by vacuum filtration
through Whatman GF/C glass fibre filters, followed by washing of
the filters and reaction tubes with 10 ml of the incubation solution,
kept at 4 °C. The filters were then placed in scintillation vials, and
5 ml of scintillation liquid (Scintran Cocktail T; Wallac, Turku,
Finland) were added. Radioactivity bound to the filters was deter-
mined after 12 h with an efficiency of 55–60% for 2 min. Mem-
brane protein was determined according to Peterson (1977).
Statistical analysis
Values are presented as the mean
S.E.M. The significance of the
differences between the means was calculated with the two-tailed
paired Student’s t-test. Values of P0.05 were considered to be
statistically significant.
RESULTS
ATP analogues facilitate LTP when adenosine A1
receptors are blocked
The application of -burst stimulation (three trains of
100 Hz, four stimuli, separated by 200 ms) in one pathway
caused LTP with an amplitude of 36.4
8.7% (n4). The
application of a similar -burst stimulation in the other
pathway in the presence of -MeATP (20 M) elicited a
smaller LTP (16.6
5.0%, n4, P0.05). This inhibitory
effect of the ATP analog is similar to the inhibition of LTP
by adenosine A1 receptor activation (de Mendonc¸a and
Ribeiro, 1990) and it is known that, under basal conditions
of stimulation, ATP analogues are locally catabolised into
adenosine and channelled to A1 receptor activation
(Cunha et al., 1998). In fact, the P2 receptor antagonists,
PPADS (10 M) or suramin (75 M), did not modify the
inhibitory effect of the ATP analog on LTP (the values of
LTP were 29.0
5.0% in control solution and 14.0
5.3% in
the presence of -MeATP (20 M) and PPADS (10 M);
and 21.5
5.2% in control solution and 12.2
5.1% in the
presence of -MeATP (20 M) and suramin (75 M;
n4, P0.05). In contrast, in the presence of the selective
adenosine A1 receptor antagonist, DPCPX (50 nM), we no
longer observed the inhibitory effect of the ATP analog. In
fact, -MeATP (20 M) facilitated LTP from 21.2
7.5%
to 47.4
5.6% (n5; P0.05; Fig. 1A, B). We also tested
another ATP analog, -Imido ATP (20 M), which did
also facilitate LTP from 16.1
8% to 41.5
5.1%, in the
presence of 50 nM DPCPX (n4; P0.05; Fig. 1C). Thus,
the inhibitory effects of the ATP analogues on LTP may be
due to adenosine A1 receptor activation rather than to a
genuine P2 receptor-mediated effect. When blocking
adenosine A1 receptors, an excitatory effect of the ATP
analogues on LTP became apparent. Therefore, to further
investigate the role of P2 receptors in the modulation of
LTP, all the subsequent experiments were performed un-
der blockade of adenosine A1 receptors with DPCPX
(50 nM). To test the modification by different drugs of the
facilitation by ATP analogues of -burst LTP, we always
compared in two different pathways of the same slice the
effect in the first pathway of DPCPX together with the
tested drug (control) with the effect in the second pathway
of the ATP analog in the presence of DPCPX and the
tested drug. This enabled us to determine if the effect of
the ATP analogues was modified by the tested drug in the
same slice, irrespective of the effect of the tested drugs on
LTP and on basal synaptic transmission. Again, it is im-
portant to stress that comparisons need to be carried out in
the same slice since we noted a considerable variation of
the amplitude of -burst LTP between slices.
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ATP antagonists prevent the facilitatory effect of
ATP analogues on LTP
We then tested the ability of antagonists of P2 receptors to
modify the facilitatory effect of ATP analogues on LTP-
induced by -burst stimulation pattern, observed in the
presence of DPCPX (50 nM; Fig. 1). The facilitatory effect
of -MeATP (20 M) on LTP was prevented by the P2
receptor antagonist PPADS (20 M), a value of
14.6
1.6% being obtained in the presence of PPADS and
-MeATP compared with a value of 16.9
3.7% when
-MeATP was not present (n3; P0.05; Fig. 2A). Like-
wise, the facilitatory effect of -Imido ATP (20 M) on
LTP was also prevented by the P2 receptor antagonist
PPADS (20 M), a value of 15.1
2.4% being obtained in
the presence of PPADS and -Imido ATP compared with
a value of 15.9
2.9% when -Imido ATP was not present
(n3, P0.05). The facilitatory effect of -Imido ATP
(20 M) on LTP was also prevented by another P2 recep-
tor antagonist, suramin (75 M), a value of 15.1
1.7%
being obtained in the presence of suramin and -Imido
ATP compared with a value of 17.6
2.0% when -Imido
ATP was not present (n3; P0.05; Fig. 2B).
The pharmacological characterisation of the P2 recep-
tors likely to be involved in the facilitation by ATP ana-
logues of -burst induced LTP is problematic due to the
poor selectivity of the P2 receptor ligands currently avail-
able (Ralevic and Burnstock, 1998). But, since -Imido
ATP was equi-effective with -MeATP, the later being
considered a P2X1/3 receptor preferring agonist (Ralevic
and Burnstock, 1998), we decided to test the ability of a
purported P2X1/P2X3 receptor antagonist, NF023 (Soto et
al., 1999; Lambrecht, 2000) to prevent the facilitatory effect
of ATP analogues. NF023 (10 M) blocked the facilitatory
effect of -Imido ATP (20 M) on LTP, a value of
25.6
10.6% being obtained in the presence of NF023 and
-Imido ATP and a value of 25.3
10.5% when -Imido
ATP was not present, (n3; Fig. 2C).
Adenosine A2A antagonists prevent the facilitatory
effect of the ATP analogues on LTP
Since it has previously been shown that endogenously
released adenine nucleotides lead to preferential activa-
tion of adenosine A2A receptors (Cunha et al., 1996c) and
activation of these A2A receptors is known to facilitate LTP
(de Mendonc¸a and Ribeiro, 1994), we thought important to
probe the participation of facilitatory adenosine A2A recep-
tors in this enhancement of LTP by ATP analogues.
Indeed, the A2A receptor antagonists, ZM 241385
(50 nM) and SCH 58261 (50 nM) prevented the facilitatory
effects of -MeATP (20 M) and of -Imido ATP
(20 M) on LTP (see Fig. 3). Thus, a value for LTP of
18.2
0.7% was obtained in the presence of ZM 241385
and -MeATP compared with a value of 17.9
0.3%
when -MeATP was not present (n4; P0.05; Fig. 3A).
The facilitatory effect of -Imido ATP (20 M) on LTP was
also prevented by ZM 241385 (50 nM), a value of
21.2
1.4% being obtained in the presence of ZM 241385
and -Imido ATP compared with a value of 22.7
1.4%
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Fig. 1. Effect of the ATP analogues, -MeATP (20 M) and -Imido
ATP (20 M), on LTP induced by -burst stimulation pattern in rat
hippocampal slices in the presence of the adenosine A1 receptor
antagonist, DPCPX (50 nM). Panels A and B show the time course of
the changes (%) in fEPSP slope. The arrow represents the time of
application of the -burst stimulation pattern. Panel A shows the facili-
tatory effect of -MeATP (20 M) on -burst-induced LTP (F) com-
pared with DPCPX (50 nM) alone (). Each point represents the
mean
S.E.M. of four experiments. Panel B presents averages of eight
consecutive fEPSP obtained before (potentials on the left) and 60 min
after induction of LTP with the -burst stimulation pattern (potentials on
the right) in the presence of DPCPX (50 nM) alone (dashed lines) and
in the simultaneous presence of DPCPX (50 nM) and -MeATP
(20 M). The experiment was carried out in the same hippocampal
slice on recording extracellularly in CA1 dendrites after stimulation of
two converging but independent afferent pathways. Panel C shows the
facilitatory effect of -Imido ATP (20 M) on -burst-induced LTP (F)
compared with DPCPX (50 nM) alone (E). Each point represents the
mean
S.E.M. of four experiments. Note that DPCPX (50 nM) caused
a 11
2% facilitation of basal fEPSP slope and -MeATP (20 M) or
-Imido ATP (20 M) were virtually devoid of effects on basal fEPSP
slope when added in the presence of DPCPX.
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when -Imido ATP was not present (n3; P0.05). Fi-
nally, the facilitatory effect of -Imido ATP (20 M) on
LTP was also prevented by SCH 58261 (50 nM), a value of
24.2
3.6% being obtained in the presence of SCH 58261
and -Imido ATP compared with a value of 24.7
3.7%
when -Imido ATP was not present (n3; P0.05; Fig. 3B).
ATP analogues do not bind to hippocampal
adenosine A2A receptors
Since adenosine A2A receptors antagonists prevented the
facilitatory effect of ATP analogues on LTP, we sought to
exclude the possibility that ATP analogues might directly
interact with adenosine A2A receptors. For that purpose,
we carried out displacement binding curves to investigate
the ability of ATP analogues to displace the binding of the
selective A2A receptor agonist [
3H]CGS 21680 to rat hip-
pocampal membranes. As shown in Fig. 4, both -
MeATP and -Imido ATP failed to displace the binding of
[3H]CGS 21680 (30 nM) to rat hippocampal membranes in
concentrations up to 100 M. This indicates that the tested
ATP analogues are unable to interact directly with adeno-
sine A2A receptors in the rat hippocampus, similarly to
what was previously observed in the striatum (Pirotton and
Boeynaems, 1993). We also found that PPADS also failed
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Fig. 2. Effect of the P2 receptor antagonists, PPADS (20 M, panel
A), suramin (75 M, panel B) and NF023 (10 M, panel C), on the
facilitation by ATP analogues of LTP induced by -burst stimulation
pattern in rat hippocampal slices. All panels show the time course of
the changes (%) in fEPSP slope. The arrow represents the time of
application of the -burst stimulation pattern. All the experiments were
performed in the presence of the adenosine A1 receptor antagonist,
DPCPX (50 nM). Panel A shows that the facilitatory effect of -
MeATP (20 M) on -burst-induced LTP is prevented in the presence
PPADS (20 M). Panel B shows that the facilitatory effect of -Imido
ATP (20 M) on -burst-induced LTP is prevented in the presence of
suramin (75 M). Panel C shows that the facilitatory effect of -Imido
ATP (20 M) on -burst-induced LTP is prevented in the presence of
NF023 (10 M). In all panels, each point represents the mean
S.E.M.
of three experiments.
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Fig. 3. Effect of A2A receptor antagonists on the facilitation by ATP
analogues of LTP induced by -burst stimulation pattern in rat hip-
pocampal slices. The panels show the time course of the changes (%)
in fEPSP slope. The arrow represents the time of application of the
-burst stimulation pattern. All the experiments were performed in the
presence of the adenosine A1 receptor antagonist, DPCPX (50 nM).
Panel A shows that the facilitatory effect of -MeATP (20 M) on
-burst-induced LTP is prevented in the presence of A2A receptor
antagonist, ZM 241385 (50 nM). Each point represents the
mean
S.E.M. of four experiments. Panel B shows that the facilitatory
effect of -Imido ATP (20 M) on -burst-induced LTP is also pre-
vented in the presence of another A2A receptor antagonist, SCH 58261
(50). Each point represents the mean
S.E.M. of three experiments.
T. Almeida et al / Neuroscience 122 (2003) 111–121 115
to displace the binding of [3H]CGS 21680 (30 nM) to rat
hippocampal membranes in concentrations up to 100 M
(Fig. 4).
ATP analogues trigger [3H]adenosine outflow from
rat hippocampal slices
Another hypothesis that would reconcile the simultaneous
involvement of P2 and A2A receptors in the facilitation of
LTP by ATP analogues would be a P2 receptor-induced
release of adenosine that would then activate adenosine
A2A receptors. Thus, we investigated if ATP analogues
could trigger adenosine outflow from rat hippocampal
slices. Fig. 5a shows that -Imido ATP (20 M) induced
a release of tritium from hippocampal slices previously
labelled with [3H]adenosine to a value 147.7
2.3% greater
than baseline (n4; P0.05). The P2 receptor antago-
nists, PPADS (10 M; n4) and suramin (75 M; n3;
data not shown), were devoid of effects on basal tritium
outflow but prevented this facilitatory effect of -Imido
ATP (20 M) on tritium outflow (Fig. 5A).
We then tried to explore if there was any particular
component in the slices that might contribute more in-
tensely for this ATP-induced adenosine release. As illus-
trated in Fig. 5B, -Imido ATP (20 M) triggered an
outflow of tritium that was greater in nerve terminals (n4)
than in slices (n3) and had similar amplitude in slices and
in cultured astrocytes (n3). The -Imido ATP (20 M)-
induced outflow of tritium from cultured neurons (n4) was
consistently lower than in all other tested hippocampal
preparations (Fig. 5B). This suggests that the P2 receptor-
evoked release of adenosine may mainly be derived from
nerve terminals and astrocytes although it should be kept
in mind that the expression and function of P2 receptors
and nucleoside transporters may be modified in cultured
neurons or astrocytes. We also confirmed that -Imido
ATP (20 M) indeed enhanced [3H]adenosine release. In
fact, -Imido ATP (20 M) enhanced by 216
12% the
outflow of adenosine from hippocampal nerve terminals
(n3). This indicates that tritium release might be a good
measure of adenosine release and show that nerve termi-
nals might be major contributors for this P2 receptor-in-
duced release of adenosine.
Adenosine transport blockers prevent the
ATP-induced [3H]adenosine outflow
The extracellular accumulation of adenosine may result
from two different sources: either from a release of aden-
osine as such through the bi-directional non-concentrative
nucleoside transporters or from the formation of adenosine
by the extracellular catabolism of released adenine nucle-
otides (Cunha, 2001). We tested the ability of inhibitors of
Fig. 4. ATP analogues and a P2 receptor antagonist are not able to
displace the binding of the selective A2A receptor agonist, [
3H]CGS
21680, to rat hippocampal membranes. The ordinates represent the
specific binding of [3H]CGS 21680 (30 nM) on subtraction of non-
specific binding determined in the presence of 2 M XAC from the total
binding, in the presence of -MeATP (filled squares, filled grey line),
of -Imido ATP (filled circles, filled black line) or of PPADS (filled
triangles, dashed line). The results are means
S.E.M from four ex-
periments performed in triplicate.
Fig. 5. ATP analogues trigger the release of tritium from rat hip-
pocampal preparations previously loaded with [3H]adenosine. All the
experiments were performed in the presence of the adenosine A1
receptor antagonist, DPCPX (50 nM). Panel A shows that -Imido
ATP (20 M) triggers an outflow of tritium from rat hippocampal slices
that is prevented by the P2 receptor antagonist, PPADS (10 M), and
by the adenosine transport inhibitors, NBTI (5 M) and dipyridamole
(Dip; 10 M), which by themselves do not modify significantly the
basal outflow of tritium. Each bar is the mean
S.E.M. of four experi-
ments. Panel B compares the ability of -Imido ATP (20 M) to
trigger tritium release from hippocampal slices (first bar from the left),
hippocampal nerve terminals (second bar from the left), cultured hip-
pocampal neurons (third bar from the left) and astrocytes (fourth bar
from the left), previously loaded with [3H]adenosine. Each bar is the
mean
S.E.M. of three to four experiments. * P0.05 when compared
with the -Imido ATP-induced tritium release from hippocampal
slices (first bar).
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nucleoside transporters, dipyridamole and NBTI, to modify
the P2 receptor-induced outflow of adenosine from rat
hippocampal slices. We observed that the simultaneous
presence of NBTI (5 M) and dipyridamole (10 M) virtu-
ally abolished the ability of -Imido ATP (20 M) to trigger
tritium outflow from rat hippocampal slices previously la-
belled with [3H]adenosine (Fig. 5A). This strongly suggests
that the ATP-induced outflow of adenosine might essen-
tially result from a release of adenosine mediated by the
bi-directional non-concentrative adenosine transporters.
Adenosine transport blockers prevent the facilitatory
effect of ATP analogues on LTP
To further reinforce our hypothesis that the facilitation by
ATP analogues of hippocampal LTP involves a P2 recep-
tor-mediated release of adenosine followed by activation of
adenosine A2A receptors, we tested the effect of NBTI and
dipyridamole on the facilitatory effect of -Imido ATP
(20 M) on LTP. The facilitatory effect of -Imido ATP
(20 M) on LTP was prevented in the presence of NBTI
(5 M) and dipyridamole (10 M), a value of 12.4
2.9%
being obtained in the presence of NBTI, dipyridamole and
-Imido ATP, compared with a value of 15.5
1.2% when
-Imido ATP was not present (n3; Fig. 6).
Activation of adenosine A2A receptors facilitates LTP
and occludes the facilitation of LTP by ATP
analogues
If indeed adenosine A2A receptor activation occurs down-
stream of P2 receptor activation, then an exogenously
added high affinity agonist of A2A receptors should by itself
facilitate -burst LTP. In fact, the prototypical A2A receptor
agonist, CGS 21680 (10 nM), enhanced -burst LTP, a
value of 47.7
2.7% being obtained in the presence of
CGS 21680 (10 nM), compared with a value of 32.6
5.6%
in the absence of CGS 21680 (n3; P0.05; Fig. 7A).
Also, if the P2 receptor-mediated facilitation of LTP
indeed depends on adenosine release followed by A2A
receptor activation then one would expect that the direct
activation of A2A receptors with CGS 21680 should oc-
clude the facilitation of LTP by ATP analogues. As pre-
dicted, CGS 21680 (10 nM) prevented the facilitation of
LTP by -Imido ATP (20 M), a value of 32.1
6.6%
being obtained in the presence of CGS 21680 and -
Imido ATP, compared with 30.4
5.3% in the absence of
-Imido ATP (n3; P0.05; Fig. 7B).
Protein kinase C, but not protein kinase A, prevents
the facilitatory effect of ATP analogues on LTP
The results so far obtained show that the effect of ATP
analogues on LTP requires the recruitment of adenosine
A2A receptors after P2 receptor-induced adenosine re-
lease. Since adenosine A2A receptor facilitation of hip-
pocampal synaptic transmission requires the activation of
protein kinase C but not protein kinase A (Cunha and
Ribeiro, 2000b), we tested the effect of the inhibitor of the
protein kinase C, chelerythrine, on the facilitatory effect of
-Imido ATP on LTP. The facilitatory effect of -Imido
Fig. 6. Effect of the two inhibitors of the bi-directional non-concentra-
tive adenosine transporters, NBTI and dipyridamole (Dip), on the
facilitation by ATP analogues of LTP induced by -burst stimulation
pattern in rat hippocampal slices. The figure shows the time course of
the changes (%) in fEPSP slope. The arrow represents the time of
application of the -burst stimulation pattern. All the experiments were
performed in the presence of the adenosine A1 receptor antagonist,
DPCPX (50 nM). The figure shows that the facilitatory effect of -
Imido ATP (20 M) on -burst-induced LTP is prevented in the pres-
ence of NBTI (5 M) and dipyridamole (Dip, 10 M). Each point
represents the mean
S.E.M. of three experiments.
Fig. 7. The adenosine A2A receptor agonist, CGS 21680, enhances
LTP and occludes the facilitatory effect of ATP analogues on LTP
induced by -burst stimulation pattern in rat hippocampal slices. Both
panels show the time course of the changes (%) in fEPSP slope. The
arrow represents the time of application of the -burst stimulation
pattern. All the experiments were performed in the presence of the
adenosine A1 receptor antagonist, DPCPX (50 nM). Panel A shows
that CGS 21680 (10 nM; F) facilitates LTP compared with its absence
(E). Panel B shows that the facilitatory effect of -Imido ATP (20 M)
on -burst-induced LTP is prevented in the presence of CGS 21680
(10 nM). Each point is the mean
S.E.M. of three experiments.
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ATP (20 M) on LTP was prevented by chelerythrine
(6 M), a value of 24.5
3.2% being obtained in the pres-
ence of chelerythrine and -Imido ATP compared with a
value of 24.1
3.2% when -Imido ATP was not present
(n2, Fig. 8A). We also tested the effect of an inhibitor of
the protein kinase A, H89, on the facilitatory effect of
-Imido ATP on LTP. The facilitatory effect of -Imido
ATP (20 M) on LTP was not prevented by H89 (1 M), a
value of 35.9
4.1% being obtained in the presence of H89
and -Imido ATP compared with a value of 21.8
2.7%
when -Imido ATP was not present (n2; Fig. 8B).
DISCUSSION
The present results show that the modulation by extracel-
lular ATP analogues of -burst-induced LTP in rat hip-
pocampal slices requires the activation of P2 receptors,
but ultimately depends on the induced release of adeno-
sine and activation of adenosine receptors. Upon blockade
of inhibitory adenosine A1 receptors, ATP activates P2
receptors that trigger an enhanced adenosine outflow
through nucleoside transporters, particularly from nerve
terminals and astrocytes, and this released adenosine
then activates facilitatory A2A receptors causing an en-
hancement of LTP via a protein kinase C-dependent
pathway.
Under basal frequencies of stimulation in rat hip-
pocampal slices (one stimulus every 20 s), the effects of
exogenously added ATP analogues are due to A1 receptor
activation upon extracellular catabolism of ATP into aden-
osine through the ecto-nucleotidase pathway (Dunwiddie
et al., 1997; Cunha et al., 1998). Although in Schaffer fibre
synapses it is possible to reveal a minor component of the
excitatory postsynaptic current mediated by P2X receptors
(Pankratov et al., 1998, 2002), it is observed that both the
neuromodulatory effects and the direct effects of exog-
enously added ATP on the post-synaptic component are
abolished by selective blockade of adenosine A1 receptors
(Dunwiddie et al., 1997) and are not observed in A1 recep-
tor knockout animals (Masino et al., 2002). In fact, the
kinetic efficiency of the ecto-nucleotidase pathway deter-
mines a fast and localised catabolism of adenine nucleo-
tides into adenosine and the channelling of the minor
amounts of adenosine formed to the highly abundant A1
receptors (Dunwiddie et al., 1997; Cunha et al., 1998), and
this occurs both presynaptically (Cunha et al., 1998) and
postsynaptically (Dunwiddie et al., 1997). We now found
that the same occurs during -burst LTP, i.e. that exog-
enously added ATP analogues inhibited LTP in a way
reminiscent of the known inhibitory effects of adenosine on
LTP (de Mendonc¸a and Ribeiro, 1990; Arai et al., 1990).
Indeed, this inhibitory effect of ATP analogues on LTP was
prevented by DPCPX, but was not modified by the P2
receptor antagonists, PPADS or suramin, indicating that
the inhibitory effects were due to the formation of adeno-
sine, and did not involve a P2 receptor-mediated action, as
recently suggested in clamped pyramidal neurons (Pan-
kratov et al., 2002). ATP analogues can thus exert inhibi-
tory effects on LTP, which are apparently not mediated by
purinergic P2 receptors and involve formation of adeno-
sine acting through adenosine A1 receptors. This likely
results from the broad distribution of ecto-nucleotidases in
different cell types in the CNS (reviewed by Zimmermann
and Braun, 1999) and to the abundance and broad distri-
bution of A1 receptors in the hippocampus (e.g. Fastbom et
al., 1987) that biases the effect of exogenously added ATP
analogues. In fact, we have previously shown that exog-
enously added and endogenously released adenine nucle-
otides produce opposite effects in the modulation of hip-
pocampal synaptic transmission (Cunha et al., 1996c).
Indeed, we now observed that, when blocking the adeno-
sine A1 receptors, excitatory effects for the ATP analogues
could be revealed, which were genuinely mediated by P2
receptors, since they were blocked by the P2 receptor
antagonists, PPADS or suramin.
At this stage, it is not possible to reliably study the role
of endogenously released ATP on LTP since the available
antagonists of P2 receptors also interfere with different
ionotropic receptors, namely with NMDA receptor function
(Nakazawa et al., 1995; Ong et al., 1997; Peoples and Li,
1998) that is of critical importance for LTP induction (Col-
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Fig. 8. Effect of a protein kinase C inhibitor (chelerythrine) and of a
protein kinase A inhibitor (H89) on the facilitation by ATP analogues of
LTP induced by -burst stimulation pattern in rat hippocampal slices.
The panels show the time course of the changes (%) in fEPSP slope.
The arrow represents the time of application of the -burst stimulation
pattern. All the experiments were performed in the presence of the
adenosine A1 receptor antagonist, DPCPX (50 nM). Panel A shows
that the facilitatory effect of -Imido ATP (20 M) on -burst-induced
LTP is prevented in the presence of chelerythrine (6 M; F) compared
with the its absence (E). Panel B shows that the facilitatory effect of
-Imido ATP (20 M) on -burst-induced LTP was not modified in the
presence of H89 (1 M; F) compared with its absence (E). Each point
represents the mean
S.E. of two experiments.
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lingridge et al., 1983). Thus, we studied the mechanisms
involved in these excitatory effects of the ATP analogues
on LTP, which might be of particular relevance since ATP
is released from stimulated hippocampal nerve terminals
(Cunha et al., 2000) and the release of ATP is dispropor-
tionally larger upon conditions of stimulation known to
induce LTP (Wieraszko et al., 1989; Cunha et al., 1996).
As previously justified, it is only possible and reasonable to
study the role of P2 receptors upon blockade of A1 recep-
tors. There are, at present, few compounds selective for
either P2X or P2Y receptor subtypes. The observation that
NF023, an antagonist moderately selective for the P2X1/3
subunit containing receptors (Soto et al., 1999; Lambrecht,
2000), prevented the facilitatory effects of ATP analogues
on LTP suggests that these receptor subtypes might be
involved, a contention that is reinforced by the immunolog-
ical confirmation of the localisation of P2X1, P2X2 and
P2X3 receptor subunits in hippocampal nerve terminals
(Rodrigues et al., manuscript in preparation). However, a
detailed pharmacological characterisation must await the
availability of more selective compounds and, at this stage,
it is not possible to exclude the eventual involvement of
P2Y receptors.
The facilitatory effects of ATP analogues on LTP were
prevented by two selective antagonists of adenosine A2A
receptors. This result was not unexpected, since activation
of P2 receptors was proposed to induce the release of
adenosine (Nikbakht and Stone, 2000a,b) and we had
previously reported that endogenously released adenine
nucleotides trigger A2A receptor activation in the hip-
pocampus at low frequencies of stimulation (Cunha et al.,
1996c). By directly measuring the amount of tritiated aden-
osine released from hippocampal slices, we confirmed that
ATP analogues markedly enhanced the outflow of adeno-
sine (Sperlagh et al., 2003). It is important to emphasise
that this enhanced adenosine outflow is actually due to de
novo purine release rather than from the extracellular ca-
tabolism of the added ATP analogues since the former is
tritiated whereas the latter are not. The observation that
the inhibitors of adenosine transporters nearly blocked this
P2 receptor-induced adenosine outflow strongly suggests
that the enhanced levels of extracellular adenosine may
essentially result from a release of adenosine as such (see
Cunha, 2001). We also found that the facilitatory effects of
the ATP analogues on LTP were prevented in the pres-
ence of the blockers of bi-directional non-concentrative
nucleoside transporters, NBTI plus dipyridamole. The
mechanism whereby activation of P2 receptors modifies
the function of nucleoside transporters is at present un-
known. But the increase in extracellular adenosine levels
activating adenosine A2A receptors seems to be manda-
tory for the facilitatory effects of the ATP analogues on
LTP, since these effects were blocked by two adenosine
A2A receptor selective antagonists, ZM 241385 and SCH
58261. Activation of the adenosine A2A receptors is known
to facilitate LTP irrespective of A1 receptor blockade (de
Mendonc¸a and Ribeiro, 1994). We now replicated and
extended this observation, showing that the adenosine A2A
receptor selective agonist, CGS 21680, facilitated  burst-
induced LTP and it has recently been reported that NMDA
receptor activation bursts A2A receptor-mediated modula-
tion of hippocampal synaptic transmission (Nikbakht and
Stone, 2001). In accordance with the previously observed
coupling of adenosine A2A receptors with protein kinase C
rather than with protein kinase A (see Cunha and Ribeiro,
2000b), we found that the facilitatory effect of the ATP
analogues on LTP were prevented by a protein kinase C
inhibitor, chelerythrine, but not by a protein kinase A inhib-
itor, H89.
Thus, the present results indicate that ATP, which is
released upon stimulation conditions that induce LTP, ac-
tivates P2 receptors that lead to facilitation of LTP by a
adenosine A2A receptor-mediated and protein kinase C-
dependent pathway. This concatenated effect of P2 and
P1 (A2A) receptors illustrates the tight interrelation be-
tween ATP and adenosine neuromodulatory systems and
reinforces our previous contention (Cunha and Ribeiro,
2000) that blockade of ATP responses by P2 receptor
antagonists does not exclude the involvement of P1 recep-
tors in physiological effects triggered by ATP. Certainly,
the present findings do not exclude that ATP released
upon stimulation might exert other effects relevant for LTP
not involving P2 receptors. In particular, ATP was reported
to extracellularly phosphorylate membrane proteins (Fujii
et al., 1995; Chen et al., 1996), although the presently
tested ATP analogues were selected because they are
poor phosphate donors (Wieraszko and Ehrlich, 1994; Ki-
miura et al., 1985). Interestingly, a brief decrease in the
activities of the enzymes that metabolise ATP to adeno-
sine, ecto-ATP diphosphohydrolase and ecto-5-nucleoti-
dase, was observed in the hippocampus when learning an
inhibitory avoidance task (Bonan et al., 1998, 2000). We
could speculate that this decreased catabolism would lead
to higher levels of ATP acting upon P2 receptors to tran-
siently facilitate the phenomena of synaptic plasticity im-
portant for memory acquisition.
In conclusion, the present work demonstrates a func-
tional role for P2 receptors in the modulation of LTP that
operate indirectly through induction of adenosine release.
Acknowledgements—This work was supported by Fundac¸a˜o para
a Cieˆncia e Tecnologia (POCTI/43633/1999 and POCTI/36372/
1999). The authors thank I. Arau´jo and J. O. Malva for their help
in the experiments using cultured hippocampal neurons and as-
trocytes.
REFERENCES
Ambro´sio AF, Silva AP, Malva JO, Soares-da-Silva P, Carvalho AP,
Carvalho AM (1999) Carbamazepine inhibits L-type Ca2 channels
in cultures rat hippocampal neurons stimulated with glutamate re-
ceptor agonists. Neuropharmacology 38:1349–1359.
Arai A, Kessler M, Lynch G (1990) The effects of adenosine on the
development of long-term potentiation. Neurosci Lett 119:41–44.
Balcar VJ, Li Y, Killinger S, Bennett MR (1995) Autoradiography of
P2X ATP receptors in the rat brain. Br J Pharmacol 115:302–306.
Bardoni R, Goldstein PA, Lee CJ, Gu JG, MacDermott AB (1997) ATP
P2X receptors mediate fast synaptic transmission in the dorsal horn
of the rat spinal cord. J Neurosci 17:5297–5304.
Bliss TVP, Collingridge GL (1993) A synaptic mode of memory: long-
term potentiation in the hippocampus. Nature 361:31–39.
T. Almeida et al / Neuroscience 122 (2003) 111–121 119
Bo X, Burnstock G (1994) Distribution of [3H]-, -methylene ATP
binding sites in rat brain and spinal cord. Neuroreport 5:1601–1604.
Bonan CD, Dias MM, Battastini AM, Dias RD, Sarkis JJ (1998) Inhib-
itory avoidance learning inhibits ectonucleotidases activities in hip-
pocampal synaptosomes of adult rats. Neurochem Res 23:977–
982.
Bonan CD, Roesler R, Pereira GS, Battastini AM, Izquierdo I, Sarkis JJ
(2000) Learning-specific decrease in synaptosomal ATP diphos-
phohydrolase activity from hippocampus and entorhinal cortex of
adult rats. Brain Res 854:253–256.
Chen WW, Wieraszko A, Hogan MV, Yang HA, Kornecki E, Erlich YH
(1996) Surface protein phosphorylation by ecto-protein kinase is
required for the maintenance of hippocampal long-term potentia-
tion. Proc Natl Acad Sci USA 93:8688–8693.
Collingridge GL, Kehl SJ, NcLennan H (1983) Excitatory amino acids
in synaptic transmission in the Schaffer collateral-commissural
pathway of the rat hippocampus. J Physiol 334:33–46.
Collo G, North RA, Kawashima E, Merlo-Pich E, Surprenant A, Buell G
(1996) Cloning of P2X5 and P2X6 receptors and the distribution and
properties of an extended family of ATP-gated ion channels. J Neu-
rosci 16:2495–2507.
Costenla AR, de Mendonc¸a A, Ribeiro JA (1999) Adenosine modu-
lates synaptic plasticity in hippocampal slices from aged rats. Brain
Res 851:228–234.
Cunha RA (2001) Adenosine as a neuromodulator and as a homeo-
static regulator in the nervous system: different roles, different
sources and different receptors. Neurochem Int 38:107–125.
Cunha RA, Ribeiro JA (2000a) ATP as a presynaptic modulator. Life
Sci 68:119–137.
Cunha RA, Ribeiro JA (2000b) Adenosine A2A receptor facilitation of
synaptic transmission in the CA1 area of the rat hippocampus
requires protein kinase C but not protein kinase A activation. Neu-
rosci Lett 289:127–130.
Cunha RA, Vizi ES, Ribeiro JA, Sebastia˜o AM (1996a) Preferential
release of ATP and its extracellular catabolism as a source of
adenosine upon high- but not low-frequency stimulation of rat hip-
pocampal slices. J Neurochem 67:2180–2187.
Cunha RA, Johansson B, Constantino MD, Sebastia˜o AM, Fredholm
BB (1996b) Evidence for high-affinity binding sites for the A2A
receptor agonist [3H]CGS 21680 in the rat hippocampus and cere-
bral cortex that are different from striatal A2A receptors. Naunyn-
Schmiedebergs Arch Pharmacol 353:261–271.
Cunha RA, Correia-de-Sa´ P, Sebastia˜o AM, Ribeiro JA (1996c) Pref-
erential activation of excitatory adenosine receptors at rat hip-
pocampal and neuromuscular synapses by adenosine formed from
released adenine nucleotides. Br J Pharmacol 119:253–260.
Cunha RA, Sebastia˜o AM, Ribeiro JA (1998) Inhibition by ATP of
hippocampal synaptic transmission requires localized extracellular
catabolism by ecto-nucleotidases into adenosine and channeling to
adenosine A1 receptors. J Neurosci 18:1987–1995.
Cunha RA, Almeida T, Ribeiro JA (2000) Modification by arachidonic
acid of extracellular adenosine metabolism and neuromodulatory
action in the rat hippocampus. J Biol Chem 275:37572–37581.
Cunha RA, Rodrigues RJ, Almeida T, Oliveira CR (2002) Modulation
of neurotransmitter release by ATP (P2) receptors in the rat hip-
pocampus. Neurosci Abst (in press).
de Mendonc¸a A, Ribeiro JA (1990) 2-Chloroadenosine decreases
long-term potentiation in the hippocampal CA1 area of the rat.
Neurosci Lett 118:107–111.
de Mendonc¸a A, Ribeiro JA (1994) Endogenous adenosine modulates
long-term potentiation in the hippocampus. Neuroscience 62:385–
390.
de Mendonc¸a A, Ribeiro JA (2001) Adenosine and synaptic plasticity.
Drug Dev Res 52:283–290.
Dunwiddie TV, Diao L, Proctor WR (1997) Adenine nucleotides un-
dergo rapid, quantitative conversion to adenosine in the extracel-
lular space in rat hippocampus. J Neurosci 17:7673–7682.
Edwards FA, Gibb AJ, Colquhoun D (1992) ATP receptor-mediated
synaptic currents in the central nervous system. Nature 359:144–
147.
Fastbom J, Pazos A, Palacios JM (1987) The distribution of adenosine
A1 receptors and 5-nucleotidase in the brain of some commonly
used experimental animals. Neuroscience 22:813–826.
Fujii S, Kato H, Furuse H, Ito KI, Osada H, Hamaguchi T, Kuroda Y
(1995) The mechanism of ATP-induced long-term potentiation in-
volves extracellular phosphorylation of membrane proteins in guin-
ea-pig hippocampal CA1 neurons. Neurosci Lett 187:130–132.
Inoue K, Koizumi S, Ueno S (1996) Implication of ATP receptors in
brain functions. Prog Neurobiol 50:483–492.
Kanjhan R, Housley GD, Burton LD, Christie DL, Kippenberger A,
Thorne PR, Luo L, Ryan AF (1999) Distribution of P2X2 receptor
subunit of the ATP-gated ion channels in the rat central nervous
system. J Comp Neurol 28:11–32.
Kidd EJ, Grahames CBA, Simon J, Michel AD, Barnard EA, Humphrey
PPA (1995) Localization of P2X purinoreceptor transcripts in the rat
nervous system. Mol Pharmacol 48:459–573.
Kimiura N, Shimada N, Tsubokura M (1985) Adenosine-5-(-imido)
triphosphate and guanosine 5-O-(2-thiodiphosphate) do not nec-
essarily provide non-phosphorylating conditions in adenylate cy-
clase studies. Biochem Biophys Res Comm 126:983–991.
Lambrecht G (2000) Agonists and antagonists acting at P2X
receptors: selectivity profiles and functional implications. Naunyn-
Schmiedebergs Arch Pharmacol 362:340–350.
Leˆ KT, Babinski K, Se´gue´la P (1998a) Central P2X4 and P2X6 channel
subunits coassemble into a novel heteromeric ATP receptor. J Neu-
rosci 18:7152–7159.
Leˆ KT, Villeneuve P, Ramjaun AR, McPherson PS, Beaudet A, Se´-
gue´la P (1998b) Sensory presynaptic and widespread somatoden-
dritic immunolocalization of central ionotropic P2X ATP receptors.
Neuroscience 83:177–190.
Masino SA, Diao L, Illes P, Zahnizer NR, Larson GA, Johansson B,
Fredholm BB, Dunwiddie TV (2002) Modulation of hippocampal
glutamatergic transmission by ATP is dependent on adenosine A1
receptors. J Pharmacol Exp Ther 303:356–363.
Mori M, Heuss C, Gahwiler BH, Gerber U (2001) Fast synaptic trans-
mission mediated by P2X receptors in CA3 pyramidal cells of rat
hippocampal slice cultures. J Physiol 535:115–123.
Nakazawa K, Inoue K, Ito K, Koizumi S, Inoue K (1995) Inhibition by
suramin and reactive blue 2 of GABA and glutamate receptor
channels in rat hippocampal neurons. Naunyn-Schmiedebergs
Arch Pharmacol 351:202–208.
Nieber K, Poelchen W, Illes P (1997) Role of ATP in fast excitatory
synaptic potentials in locus coeruleus neurones of the rat. Br J
Pharmacol 122:423–430.
Nikbakht MR, Stone TW (2000a) Suramin-sensitive suppression of
paired-pulse inhibition by adenine nucleotides in rat hippocampal
slices. Neurosci Lett 278:45–48.
Nikbakht MR, Stone TW (2000b) Complex hippocampal responses to
ATP: fade due to nucleotidase inhibition and P2-receptor-mediated
adenosine release. Brain Res 860:161–165.
Nikbakht MR, Stone TW (2001) Suppression of presynaptic responses
to adenosine by activation of NMDA receptors. Eur J Pharmacol
427:13–25.
North RA, Surprenant A (2000) Pharmacology of cloned P2X recep-
tors. Annu Rev Pharmacol Toxicol 40:63–580.
O’Kane EM, Stone TW (2000) Characterisation of ATP-induced facil-
itation of transmission in rat hippocampus. Eur J Pharmacol 409:
159–166.
Ong WY, Motin LG, Hansen MA, Dias LS, Ayrout C, Bennett MR,
Balcar VJ (1997) P2 purinoceptor blocker suramin antagonises
NMDA receptors and protects against excitatory behaviour caused
by NMDA receptor agonist (RS)-(tetrazol-5-yl)-glycine in rats.
J Neurosci Res 49:627–638.
Pankratov Y, Castro E, Miras-Portugal MT, Krishtal O (1998) A puri-
nergic component of the excitatory postsynaptic current mediated
T. Almeida et al / Neuroscience 122 (2003) 111–121120
by P2X receptors in the CA1 neurons of the rat hippocampus. Eur
J Neurosci 10:3898–3902.
Pankratov YV, Lalo UV, Krishtal OA (2002) Role for P2X receptors in
long-term potentiation. J Neurosci 22:8363–8369.
Peterson GL (1977) A simplification of the protein assay method of
Lowry et al., which is more generally applicable. Anal Biochem
83:346–356.
Peoples RW, Li C (1998) Inhibition of NMDA-gated ion channels by the
P2 purinoceptor antagonists suramin and reactive blue 2 in mouse
hippocampal neurones. Br J Pharmacol 124:400–408.
Pirotton S, Boeynaems JM (1993) Evidence that ATP, ADP and AMP
are not ligands of the striatal adenosine A2A receptor. Eur J Phar-
macol 241:55–61.
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines.
Pharmacol Rev 50:413–492.
Rubio ME, Soto F (2001) Distinct localization of P2X receptors at
excitatory postsynaptic specializations. J Neurosci 21:641–653.
Saneto RP, de Vellis J (1987) Neuronal and glial cells: cell culture of
the central nervous system. In: Neurochemistry: a practical ap-
proach (Turner AJ, Bachelard HS, eds), pp 27–63. London: IRL
Press.
Se´gue´la P, Haghighi A, Soghomonian JJ, Cooper E (1996) A novel
neuronal P2X ATP receptor ion channel with widespread distribu-
tion in the brain. J Neurosci 16:448–455.
Soto F, Garcia-Guzman M, Gomez-Hernandez JM, Hollmann M, Kar-
schin C, Stuhmer P (1996) P2X4: an ATP-activated ionotropic
receptor cloned from rat brain. Proc Natl Acad Sci USA 93:3684–
3688.
Soto F, Lambrecht G, Nickel P, Stuhmer W, Busch AE (1999) Antag-
onistic properties of the suramin analogue NF023 at heterologously
expressed P2X receptors. Neuropharmacology 38:141–149.
Sperlagh B, Szabo G, Erdelyi F, Baranyi M, Vizi ES (2003) Homo- and
heteroexchange of adenine nucleotides and nucleosides in rat hip-
pocampal slices by the nucleoside transport system. Br J Pharma-
col 139:623–633.
Tanaka J, Murate M, Wang CZ, Seino S, Iwanaga T (1996) Cellular
distribution of the P2X4 ATP receptor mRNA in the brain and
non-neuronal organs of the rat. Arch Histol Cytol 59:485–490.
Thomas T, Spyer KM (2000) ATP as a modulator of mammalian
central CO2 chemoreception. J Physiol 523:441–447.
Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell
G (1994) A new class of ligand-gated ion channel defined by P2X
receptor for extracellular ATP. Nature 371:516–519.
Wieraszko A, Ehrlich YH (1994) On the role of extracellular ATP in the
induction of long-term potentiation in the hippocampus. J Neuro-
chem 63:1731–1738.
Wieraszko A, Seyfried TN (1989) ATP-induced synaptic potentiation in
hippocampal slices. Brain Res 491:356–359.
Wieraszko A, Goldsmith G, Seyfried TN (1989) Stimulation-dependent
release of adenosine triphosphate from hippocampal slices. Brain
Res 485:244–250.
Worthington RA, Arumugam TV, Hansen MA, Balcar VJ, Barden JA
(1999) Identification and localisation of ATP P2X receptors in rat
midbrain. Electrophoresis 20:2077–2080.
Zimmermann H, Braun N (1999) Ecto-nucleotidases: molecular struc-
tures, catalytic properties, and functional roles in the nervous sys-
tem. Prog Brain Res 120:371–385.
(Accepted 9 July 2003)
T. Almeida et al / Neuroscience 122 (2003) 111–121 121
